Vasoactive intestinal peptide shapes first‐trimester placenta trophoblast, vascular, and immune cell cooperation

Abstract

The results suggest that VIP assists the progress of EVT invasion and vessel remodelling in first-trimester placental bed in an immunologically "silent" milieu. The effects of VIP in the present ex vivo human placental model endorse its potential as a therapeutic candidate for deep placentation disorders.